Clinical Role of Blood Levels
- 1 January 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 2 (1) , 3-10
- https://doi.org/10.1097/00007691-198001000-00002
Abstract
The impact of drug level monitoring on practice and quality of therapy is discussed. Analysis of the literature and a more detailed discussion of three model drugs (salicylates, digoxin, and theophylline) show a surprisingly low degree of attention to the problem of evaluating the clinical relevance of a drug monitoring program through controlled studies and techniques. There is a potential, and possibly already existing, gap between clinical pharmacokinetics and routine therapy. Closer assessment of these points, with emphasis on educational programs, should be considered among the frontiers leading to a better integration of therapeutic monitoring into medical practice.This publication has 6 references indexed in Scilit:
- Use of Laboratory Tests in a Teaching Hospital: Long-Term TrendsAnnals of Internal Medicine, 1979
- Doses and dosage intervals of drugs—clinical practice and pharmacokinetic principlesClinical Pharmacology & Therapeutics, 1978
- Rational aspirin dosage regimensClinical Pharmacology & Therapeutics, 1978
- Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritisClinical Pharmacology & Therapeutics, 1977
- HOW DOCTORS DEAL WITH EPILEPSYThe Lancet, 1977
- The Serum Digitalis Concentration — Does It Diagnose Digitalis Toxicity?New England Journal of Medicine, 1976